Stock listing
NASDAQ:EUDA EUDA Health Holdings Limited Stock
Home listing (NASDAQ) of EUDA Health Holdings Limited
Follow EUDA Health Holdings Limited into a list and get an email when it puts out news.
Share price · NASDAQ:EUDA
$15.96 USD +0.94 (+6.3%)
Close on Nov 20, 2026
- Day range
- $15.96 – $17.99 USDNov 20, 2026
- Volume
- 36,512 sharesNov 20, 2026
- Market cap
- $47.79M USDAt the close on Nov 20, 2026 · price × 2.99M shares outstanding
- 52-week range
- $5.26 – $68.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $532,269 USDMedian day 22,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:EUDA · Home | $15.96 USD | +0.94 (+6.3%) | 36,512 | $17.50 | $17.99 | $15.96 | $15.02 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:EUDA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $15.96 | +0.94 | +6.3% | $17.50 | $17.99 | $15.96 | 36,512 | |
| $15.02 | -0.29 | -1.9% | $14.85 | $15.50 | $14.80 | 54,862 | |
| $15.31 | -0.015 | -0.1% | $15.05 | $15.60 | $14.76 | 101,343 | |
| $15.33 | -0.225 | -1.4% | $15.85 | $15.85 | $15.33 | 3,922 | |
| $15.55 | -0.25 | -1.6% | $14.27 | $15.79 | $14.27 | 6,862 | |
| $15.80 | +0.15 | +1.0% | $15.72 | $15.80 | $15.59 | 1,567 | |
| $15.65 | +0.99 | +6.8% | $15.27 | $15.69 | $15.17 | 21,357 | |
| $14.66 | +0.48 | +3.4% | $14.53 | $15.47 | $14.38 | 27,480 | |
| $14.18 | +0.67 | +5.0% | $13.95 | $14.45 | $13.71 | 29,022 | |
| $13.51 | -1.31 | -8.8% | $15.35 | $16.01 | $13.51 | 28,841 | |
| $14.82 | -1.18 | -7.4% | $15.39 | $16.28 | $14.50 | 12,608 | |
| $16.00 | +0.09 | +0.6% | $16.01 | $16.66 | $15.90 | 79,493 | |
| $15.91 | +0.34 | +2.2% | $15.71 | $16.48 | $15.45 | 42,482 | |
| $15.57 | -2.13 | -12.0% | $16.65 | $16.67 | $15.57 | 87,063 | |
| $17.70 | +2.20 | +14.2% | $16.65 | $17.70 | $16.55 | 35,611 | |
| $15.50 | +0.20 | +1.3% | $15.15 | $16.04 | $15.15 | 44,998 | |
| $15.30 | +0.54 | +3.7% | $14.56 | $16.44 | $14.56 | 69,657 | |
| $14.76 | +0.30 | +2.1% | $14.62 | $15.49 | $14.14 | 84,940 | |
| $14.46 | +1.68 | +13.1% | $13.31 | $15.14 | $13.02 | 83,988 | |
| $12.78 | -0.589 | -4.4% | $13.80 | $14.38 | $12.78 | 5,755 | |
| $13.37 | -1.071 | -7.4% | $13.95 | $14.70 | $13.00 | 60,195 | |
| $14.44 | -0.46 | -3.1% | $15.11 | $15.51 | $14.31 | 78,393 | |
| $14.90 | -0.10 | -0.7% | $14.70 | $15.48 | $14.57 | 120,260 | |
| $15.00 | -0.40 | -2.6% | $14.44 | $15.95 | $14.40 | 19,211 | |
| $15.40 | -0.09 | -0.6% | $15.38 | $16.06 | $15.00 | 59,400 | |
| $15.49 | +0.091 | +0.6% | $15.49 | $16.98 | $15.12 | 98,800 | |
| $15.40 | -1.61 | -9.5% | $16.25 | $16.25 | $14.96 | 9,000 | |
| $17.01 | +0.629 | +3.8% | $16.54 | $17.01 | $16.04 | 80,500 | |
| $16.38 | -2.095 | -11.3% | $17.70 | $17.86 | $16.11 | 44,800 | |
| $18.48 | -0.124 | -0.7% | $17.60 | $18.60 | $17.57 | 12,800 | |
| $18.60 | -0.44 | -2.3% | $18.44 | $19.50 | $17.06 | 36,200 | |
| $19.04 | -0.351 | -1.8% | $19.13 | $20.20 | $18.25 | 10,400 | |
| $19.39 | +2.09 | +12.1% | $17.70 | $19.77 | $17.11 | 13,600 | |
| $17.30 | +0.064 | +0.4% | $17.29 | $17.85 | $16.99 | 6,000 | |
| $17.24 | +1.326 | +8.3% | $15.98 | $17.29 | $15.70 | 15,500 | |
| $15.91 | +1.61 | +11.3% | $14.53 | $15.92 | $14.21 | 13,600 | |
| $14.30 | -1.603 | -10.1% | $15.30 | $15.46 | $14.30 | 12,300 | |
| $15.90 | -0.297 | -1.8% | $16.41 | $16.47 | $15.90 | 5,400 | |
| $16.20 | -1.662 | -9.3% | $17.00 | $17.74 | $16.20 | 8,500 | |
| $17.86 | +1.442 | +8.8% | $16.42 | $17.86 | $16.42 | 21,100 | |
| $16.42 | -0.91 | -5.3% | $17.48 | $17.48 | $16.42 | 24,700 | |
| $17.33 | +0.045 | +0.3% | $16.20 | $18.03 | $16.20 | 23,200 | |
| $17.29 | -0.095 | -0.5% | $18.00 | $18.10 | $16.67 | 21,500 | |
| $17.38 | -0.24 | -1.4% | $18.06 | $19.53 | $16.75 | 28,000 | |
| $17.62 | +0.20 | +1.1% | $17.20 | $18.17 | $17.10 | 30,700 | |
| $17.42 | +0.835 | +5.0% | $16.32 | $17.65 | $16.32 | 21,000 | |
| $16.59 | -0.365 | -2.2% | $17.39 | $17.39 | $16.28 | 22,200 | |
| $16.95 | +0.39 | +2.4% | $16.51 | $17.50 | $16.50 | 14,300 | |
| $16.56 | +3.11 | +23.1% | $13.87 | $18.66 | $13.87 | 75,000 | |
| $13.45 | +0.33 | +2.5% | $13.12 | $14.50 | $12.30 | 109,400 | |
| $13.12 | +0.02 | +0.2% | $13.53 | $13.65 | $12.06 | 44,300 | |
| $13.10 | -0.34 | -2.5% | $13.15 | $13.80 | $13.10 | 23,100 | |
| $13.44 | -0.05 | -0.4% | $13.47 | $14.00 | $13.04 | 27,000 | |
| $13.49 | -0.91 | -6.3% | $14.50 | $14.50 | $13.00 | 18,100 | |
| $14.40 | +0.56 | +4.0% | $13.68 | $14.58 | $13.47 | 86,500 | |
| $13.84 | +0.21 | +1.5% | $13.40 | $14.28 | $13.40 | 8,200 | |
| $13.63 | +0.08 | +0.6% | $13.58 | $14.28 | $13.50 | 10,700 | |
| $13.55 | -1.065 | -7.3% | $14.73 | $15.08 | $13.14 | 14,200 | |
| $14.62 | -0.415 | -2.8% | $15.46 | $15.50 | $14.50 | 7,700 | |
| $15.03 | +0.93 | +6.6% | $13.95 | $15.03 | $13.51 | 12,500 | |
| $14.10 | -0.30 | -2.1% | $14.50 | $14.58 | $14.10 | 8,300 | |
| $14.40 | -1.00 | -6.5% | $14.82 | $17.42 | $14.40 | 12,013 | |
| $15.40 | +2.19 | +16.6% | $13.50 | $16.00 | $13.49 | 9,825 | |
| $13.21 | -0.99 | -7.0% | $13.15 | $13.21 | $12.73 | 1,600 | |
| $14.20 | -0.288 | -2.0% | $13.73 | $17.42 | $13.11 | 13,900 |
Splits
1 split · NASDAQ:EUDA · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-20 | Consolidation |
- Ticker
- NASDAQ:EUDA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 16, 2026
EUDA Health Subsidiary Melana International Wins Golden Bull Award 2026 Singapore
Latest news
EUDA Health Subsidiary Melana International Wins Golden Bull Award 2026 Singapore
Nov 16, 2026
Closed $15.33 (-1.4%) on Nov 16, 2026
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
Aug 26, 2026
Closed $14.10 (-2.1%) on Aug 26, 2026
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
Jul 30, 2026
Closed $19.56 (-3.9%) on Jul 30, 2026
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
Jul 28, 2026
Closed $19.90 (+4.7%) on Jul 28, 2026
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
Jun 1, 2026
Closed $16.73 (-7.4%) on Jun 1, 2026
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
Jun 1, 2026
Closed $16.73 (-7.4%) on Jun 1, 2026
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
Apr 28, 2026
Closed $12.00 (-6.7%) on Apr 28, 2026
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
Apr 27, 2026
Closed $12.86 (+21.1%) on Apr 27, 2026
EUDA Announces Reverse Stock Split of its Ordinary Shares
Mar 19, 2026
Closed $7.97 (-15.2%) on Mar 19, 2026
EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant
Mar 4, 2026
Closed $15.75 (-2.7%) on Mar 4, 2026
EUDA Health Holdings Limited on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 19 in the last 12 months · 41 in all · newest Nov 16, 2026 · oldest 2022
- Decks
- 3 decks · latest July 2022
Where EUDA Health Holdings Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:EUDA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:EUDA | BOATS | United States | USD |
Valuation
EV/sales 7.0× against a median of 1.2×: the highest of 11 Health care services companies shown. Statements: Year to Dec 31, 2025 · price Nov 20, 2026
- Enterprise value
- $47.44M USD
- P/E
- Loss
- EV/sales
- 7.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- Negative equity
- Gross margin
- 43.9%
- Operating margin
- −36.3%
- Net margin
- −40.6%
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 0.38
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| EUDA Health Holdings Limited · NASDAQ:EUDA | US$47.79M | US$47.44M | n/a | 7.0× | n/a | n/a | −40.6% | n/a | 0.38 |
| Klea Holding · EURONEXT:ALKLH | US$54.39M | US$56.24M | 21.7× | 2.3× | 10.1× | 1.8× | 10.3% | 0.1× | n/a |
| PT Kedoya Adyaraya Tbk · IDX:RSGK | US$54.02M | US$51.70M | 28.7× | 1.8× | 9.6× | 1.2× | 6.7% | 0.0× | n/a |
| Kaya Limited · NSE:KAYA | US$53.76M | US$53.76M | n/a | 2.2× | n/a | n/a | −42.3% | n/a | n/a |
| One Health Group PLC · LSE:OHGR | US$53.58M | US$40.50M | 19.6× | 1.0× | 12.4× | 3.2× | 6.6% | 0.1× | n/a |
| Aikchol Hospital Public Co. Ltd. · SET:AHC | US$52.53M | US$13.43M | 21.3× | 0.3× | 2.8× | 0.8× | 4.9% | 0.0× | n/a |
| SHL Telemedicine Ltd. · SIX:SHLTN | US$45.68M | US$37.05M | n/a | 0.6× | 11.3× | 1.1× | −26.2% | 0.3× | n/a |
| Ma Kuang Healthcare Holding Limited · TPEX:4139 | US$44.79M | US$49.21M | n/a | 1.5× | 9.0× | 3.6× | −9.4% | 0.5× | n/a |
| MeVis Medical Solutions AG · XETR:M3V | US$43.94M | US$39.94M | 28.9× | 2.4× | 13.6× | 2.3× | 8.9% | 0.0× | n/a |
| AirSculpt Technologies, Inc. · NASDAQ:AIRS | US$43.67M | US$65.15M | n/a | 0.4× | 13.1× | 0.4× | −6.4% | 0.3× | 3.04 |
| Lokman Hekim Engurusag Saglik, Turizm, Egitim Hizmetleri ve Insaat Taahhut A.S. · BIST:LKMNH | US$42.82M | US$52.79M | 18.4× | 0.6× | 2.5× | 0.8× | 2.4% | 0.2× | n/a |
| Median of the others | US$49.11M | US$50.46M | 21.5× | 1.2× | 10.1× | 1.2× | 3.6% | 0.1× | 3.04 |
Forecasts
1 strong buy · Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 55.00 USD · Analysts' mean
- EPS, year to Dec 2026
- 1.60 · 1 analyst
- Revenue, year to Dec 2026
- 27.23M · 1 analyst
Team and board
| Officer | Role |
|---|---|
| Alfred Lim | CEO |
| Vivian Tay | Interim Chief Financial Officer |
| Johnson Tang | Managing Director, EUDA Health Malaysia Sdn Bhd |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2025 | Oct 1, 2025 | +18.7% |
| Quarter to Mar 31, 2025 | Jun 4, 2025 · Before open | −4.2% |
| Quarter to Sep 30, 2024 | Oct 18, 2024 | −5.6% |
| Quarter to Sep 30, 2022 | Nov 22, 2022 | −28.6% |
| Quarter to Jun 30, 2022 | Aug 29, 2022 | +0.1% |
| Q1 2022 | May 25, 2022 | −0.3% |
| Quarter to Dec 31, 2021 | Mar 8, 2022 | +0.1% |
| Quarter to Sep 30, 2021 | Nov 22, 2021 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| SPAC Merger (July 2022) | SPAC merger | 36 slides | July 2022 |
| 8i Acquisition 2 — SPAC Merger (June 2022) | SPAC merger | 36 slides | Jun 10, 2022 |
| SPAC Merger (April 2022) | SPAC merger | 34 slides | Apr 12, 2022 |
Financings
| Raise | Date |
|---|---|
| Warrant Cancelled: US$100,000 · Warrants at US$2 Buyers: Streeterville Capital, LLC (warrant repurchased in full and cancelled) Use of proceeds: Growth initiatives including new centers, partnerships and technology across Asia | Mar 4, 2026 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Went public as 8i Acquisition 2 Corp., a blank check company (SPAC). Priced at US$10.00 a unit on Nov 22, 2021.
- Price
- US$10.00 a unit
- Units offered
- 7,500,000 units
- Offering size
- US$75 million
- Underwriters' option
- Up to 1,125,000 more units
- Listing
- LAXXU on the Nasdaq Global Market
- Underwriter
- Maxim Group LLC
- Units delivered
- On or about Nov 24, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Apr 19, 2021 |
| Filed publicly | May 24, 2021 |
| Amended 5 times | Newest Nov 9, 2021 |
| Shares registered with an exchange | Jul 27, 2021 |
| Declared effective by the SEC | Nov 22, 2021 |
| Final prospectus, with the price | Nov 22, 2021 |
Filings
| Filing | Filed |
|---|---|
| EFFECT · Notice that a registration is effective | Nov 22, 2021 |
| 424B4 · Prospectus | Nov 22, 2021 |
| CORRESP · Letter to the SEC | Nov 17, 2021 |
| CORRESP · Letter to the SEC | Nov 17, 2021 |
| S-1/A · Registration statement, amended | Nov 9, 2021 |
| S-1/A · Registration statement, amended | Oct 4, 2021 |
| CORRESP · Letter to the SEC | Oct 1, 2021 |
| UPLOAD · Letter from the SEC | Sep 23, 2021 |
| S-1/A · Registration statement, amended | Sep 17, 2021 |
| CORRESP · Letter to the SEC | Sep 17, 2021 |
All 29 filings
| Filing | Filed |
|---|---|
| UPLOAD · Letter from the SEC | Sep 3, 2021 |
| CORRESP · Letter to the SEC | Aug 27, 2021 |
| UPLOAD · Letter from the SEC | Aug 26, 2021 |
| CORRESP · Letter to the SEC | Jul 27, 2021 |
| CORRESP · Letter to the SEC | Jul 27, 2021 |
| CERT · Exchange's certificate of listing | Jul 27, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Jul 27, 2021 |
| CORRESP · Letter to the SEC | Jul 22, 2021 |
| CORRESP · Letter to the SEC | Jul 22, 2021 |
| CORRESP · Letter to the SEC | Jul 1, 2021 |
| S-1/A · Registration statement, amended | Jul 1, 2021 |
| UPLOAD · Letter from the SEC | Jun 24, 2021 |
| CORRESP · Letter to the SEC | Jun 16, 2021 |
| S-1/A · Registration statement, amended | Jun 16, 2021 |
| UPLOAD · Letter from the SEC | Jun 10, 2021 |
| S-1 · Registration statement | May 24, 2021 |
| CORRESP · Letter to the SEC | May 24, 2021 |
| UPLOAD · Letter from the SEC | May 14, 2021 |
| DRS · Draft registration statement | Apr 19, 2021 |
Open IPO · From the cover of the final prospectus (424B4) filed Nov 22, 2021
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 6.82M | 4.01M | 3.71M | 3.76M | 4.56M | |
| Cost of revenue | 3.83M | 3.25M | 2.86M | 2.89M | 3.31M | |
| Gross profit | 2.99M | 762.2K | 842.1K | 870.0K | 1.25M | |
| Research and development | 249 | 17.2K | 129.3K | |||
| Operating income | -2.48M | -17.3M | -3.96M | -12.2M | -1.99M | -560.0K |
| Depreciation and amortization | 195.2K | 173.2K | 119.3K | 172.0K | 5.01K | |
| EBITDA | -2.28M | -17.2M | -3.84M | -12.0M | -555.0K | |
| Interest expense | 228.6K | 44.9K | 23.2K | |||
| Income before tax | -2.73M | -17.6M | -8.43M | -25.0M | 1.67M | |
| Income tax | 41.9K | -4.38K | -20.8K | 46.5K | ||
| Net income | -2.77M | -15.4M | -10.0M | -24.9M | -1.76M | 864.8K |
| Earnings per share, basic | -1.48 | -9.46 | -8.77 | -2.07 | -0.72 | 0.09 |
| Earnings per share, diluted | -1.48 | -9.46 | -8.77 | -2.07 | 0.09 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 345.1K | 237.6K | 189.0K | 57.5K | 193.5K | 190.0K |
| Receivables | 242.6K | 146.2K | 237.5K | 192.9K | 1.80M | |
| Inventory | 2.84K | 129.0K | ||||
| Current assets | 1.04M | 762.9K | 723.4K | 25.0M | 86.8M | 4.35M |
| Property, plant and equipment | 137.3K | 87.7K | 6.73K | 11.5K | 56.9K | |
| Goodwill | 0 | 0 | 992.7K | |||
| Total assets | 1.72M | 1.70M | 1.31M | 25.6M | 86.8M | 8.00M |
| Accounts payable | 14.1K | 25.9K | 1.29K | 1.64M | 359.7K | |
| Current liabilities | 5.84M | 4.14M | 8.72M | 29.1M | 7.32M | |
| Total liabilities | 5.98M | 4.27M | 8.79M | 29.1M | 4.73M | 7.40M |
| Shareholders' equity | -4.25M | -2.55M | -7.50M | -3.52M | -3.72M | 521.2K |
| Shares outstanding | 1.89M | 1.86M | 24.6M | 20.2M | 2.45M | 9.33M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Cash from operations | -2.43M | -2.03M | -2.92M | -1.53M | -1.01M | 443.9K |
| Capital spending | -77.3K | -96.8K | -18.1K | -1.10K | ||
| Free cash flow | -2.50M | -2.13M | -1.54M | 442.8K | ||
| Cash from investing | -104.5K | -147.8K | -268.2K | -86.3M | -356.2K | |
| Cash from financing | 2.55M | 2.32M | 2.35M | 2.49M | 87.4M | -168.4K |
| Change in cash | 107.5K | 40.1K | -586.9K | 594.5K | 193.5K | -60.8K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 6-K · Report of a foreign issuer | Nov 16, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Nov 3, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 13, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 13, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Sep 29, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 26, 2026 | Current report | SEC |
| 424B3 · Prospectus | Aug 11, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Aug 11, 2026 | Other filings | SEC |
| F-3/A · Registration statement, amended | Jul 31, 2026 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Jul 31, 2026 | Current report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 6-K · Report of a foreign issuer | Jul 28, 2026 | Current report | SEC |
| 424B5 · Prospectus | Jul 22, 2026 | Offer document | SEC |
| F-3/A · Registration statement, amended | Jul 17, 2026 | Offer document | SEC |
| F-3/A · Registration statement, amended | Jul 7, 2026 | Offer document | SEC |
| 424B5 · Prospectus | Jun 11, 2026 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Jun 10, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jun 8, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Jun 5, 2026 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Jun 1, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jun 1, 2026 | Current report | SEC |
| F-3 · Registration statement | May 26, 2026 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Apr 28, 2026 | Current report | SEC |
| 20-F · Annual report | Apr 28, 2026 | Annual report | SEC |
| 6-K · Report of a foreign issuer | Apr 27, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Mar 19, 2026 | Current report | SEC |
| 3 · Initial statement of ownership | Mar 18, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 18, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 18, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 18, 2026 | Insider trade | SEC |
| 6-K · Report of a foreign issuer | Mar 5, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Mar 2, 2026 | Current report | SEC |
| 424B5 · Prospectus | Mar 2, 2026 | Offer document | SEC |
| 424B5 · Prospectus | Jan 23, 2026 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Jan 15, 2026 | Current report | SEC |
| 424B5 · Prospectus | Jan 13, 2026 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Jan 13, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jan 13, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jan 7, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Dec 30, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Dec 29, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Dec 23, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Dec 22, 2025 | Current report | SEC |
| 424B5 · Prospectus | Dec 19, 2025 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Dec 19, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Dec 8, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Dec 5, 2025 | Current report | SEC |
| 424B5 · Prospectus | Dec 4, 2025 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Dec 4, 2025 | Current report | SEC |
| 424B5 · Prospectus | Nov 18, 2025 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Nov 17, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 28, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 23, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 20, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 3, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 1, 2025 | Current report | SEC |
| UPLOAD · Letter from the SEC | Sep 25, 2025 | Other filings | SEC |
| 20-F/A · Annual report, amended | Sep 24, 2025 | Annual report | SEC |
| CORRESP · Letter to the SEC | Sep 24, 2025 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Sep 22, 2025 | Current report | SEC |
| UPLOAD · Letter from the SEC | Sep 17, 2025 | Other filings | SEC |
| 20-F/A · Annual report, amended | Sep 11, 2025 | Annual report | SEC |
| CORRESP · Letter to the SEC | Sep 11, 2025 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Sep 10, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Sep 4, 2025 | Current report | SEC |
| UPLOAD · Letter from the SEC | Aug 29, 2025 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Aug 28, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Aug 26, 2025 | Current report | SEC |
| 6-K/A · Report of a foreign issuer, amended | Aug 8, 2025 | Current report | SEC |
| 424B5 · Prospectus | Aug 8, 2025 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Aug 6, 2025 | Current report | SEC |
| 424B5 · Prospectus | Jun 23, 2025 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Jun 23, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jun 2, 2025 | Current report | SEC |
| 20-F · Annual report | Apr 29, 2025 | Annual report | SEC |
| 6-K · Report of a foreign issuer | Apr 24, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Feb 10, 2025 | Current report | SEC |
| 6-K · Report of a foreign issuer | Dec 16, 2024 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Nov 5, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 31, 2024 | Other filings | SEC |
| F-3/A · Registration statement, amended | Oct 30, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Oct 25, 2024 | Other filings | SEC |
| F-3 · Registration statement | Oct 18, 2024 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Oct 18, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Oct 10, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Sep 9, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 29, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 3, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jun 26, 2024 | Current report | SEC |
| 20-F · Annual report | May 8, 2024 | Annual report | SEC |
| 6-K · Report of a foreign issuer | May 8, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | May 7, 2024 | Current report | SEC |
| NT 20-F | Apr 30, 2024 | Explanation request | SEC |
| 6-K · Report of a foreign issuer | Apr 30, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Apr 22, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Apr 4, 2024 | Current report | SEC |
| SC 13G · Big-stake notice | Mar 27, 2024 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Mar 5, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Feb 23, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jan 22, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jan 17, 2024 | Current report | SEC |
| 6-K · Report of a foreign issuer | Dec 29, 2023 | Current report | SEC |
| 424B3 · Prospectus | Sep 22, 2023 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Sep 22, 2023 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Sep 22, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 19, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 8, 2023 | Other filings | SEC |
| F-1/A · Registration statement, amended | Sep 8, 2023 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Sep 1, 2023 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Aug 14, 2023 | Current report | SEC |
| CORRESP · Letter to the SEC | Aug 4, 2023 | Other filings | SEC |
| F-1/A · Registration statement, amended | Aug 4, 2023 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Aug 2, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Jul 31, 2023 | Quarterly report | SEC |
| 6-K · Report of a foreign issuer | Jul 3, 2023 | Current report | SEC |
| 10-K · Annual report | Jun 28, 2023 | Annual report | SEC |
| 4 · Change in ownership | Jun 20, 2023 | Insider trade | SEC |
| 8-K · Current report | Jun 15, 2023 | Current report | SEC |
| 8-K · Current report | Jun 9, 2023 | Material contract | SEC |
| 3 · Initial statement of ownership | Jun 8, 2023 | Insider trade | SEC |
| D | May 31, 2023 | Other filings | SEC |
| SC 13D/A · Big-stake notice, amended | May 26, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | May 26, 2023 | Insider trade | SEC |
| 8-K · Current report | May 26, 2023 | Material contract | SEC |
| 8-K · Current report | May 24, 2023 | Management or board change | SEC |
| 3 · Initial statement of ownership | May 23, 2023 | Insider trade | SEC |
| NT 10-Q · Late filing notice | May 19, 2023 | Explanation request | SEC |
| 8-K · Current report | May 19, 2023 | Current report | SEC |
| 8-K · Current report | May 19, 2023 | Management or board change | SEC |
| 8-K · Current report | May 11, 2023 | Management or board change | SEC |
| 8-K · Current report | Apr 10, 2023 | Current report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2023 | Explanation request | SEC |
| 8-K · Current report | Mar 15, 2023 | Management or board change | SEC |
| 8-K · Current report | Mar 7, 2023 | Management or board change | SEC |
| 8-K · Current report | Mar 1, 2023 | Current report | SEC |
| 8-K · Current report | Feb 16, 2023 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 7, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Jan 31, 2023 | Management or board change | SEC |
| UPLOAD · Letter from the SEC | Jan 4, 2023 | Other filings | SEC |
| S-1 · Registration statement | Dec 23, 2022 | Offer document | SEC |
| SC 13G/A · Big-stake notice, amended | Dec 9, 2022 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 25, 2022 | Insider trade | SEC |
| SC 13D · Big-stake notice | Nov 25, 2022 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Nov 25, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 25, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 25, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 25, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 25, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 25, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 25, 2022 | Insider trade | SEC |
| SC 13D · Big-stake notice | Nov 25, 2022 | Big-stake notice | SEC |
| 8-K · Current report | Nov 23, 2022 | Acquisition or disposal | SEC |
| SC 13G · Big-stake notice | Nov 23, 2022 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 22, 2022 | Quarterly report | SEC |
| 25-NSE | Nov 17, 2022 | Other filings | SEC |
| 25-NSE | Nov 17, 2022 | Other filings | SEC |
| DEFA14A · Additional proxy material | Nov 14, 2022 | Meeting notice | SEC |
| 8-K · Current report | Nov 14, 2022 | Material contract | SEC |
| 8-K · Current report | Nov 10, 2022 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Nov 10, 2022 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 10, 2022 | Meeting notice | SEC |
| 8-K · Current report | Nov 10, 2022 | Material contract | SEC |
| 8-K · Current report | Nov 7, 2022 | Material contract | SEC |
| DEFA14A · Additional proxy material | Nov 7, 2022 | Meeting notice | SEC |
| UPLOAD · Letter from the SEC | Oct 13, 2022 | Other filings | SEC |
| DEFM14A | Oct 13, 2022 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Oct 6, 2022 | Meeting notice | SEC |
| 8-K · Current report | Oct 6, 2022 | Current report | SEC |
| CORRESP · Letter to the SEC | Sep 8, 2022 | Other filings | SEC |
| PRER14A | Sep 8, 2022 | Other filings | SEC |
| DEFA14A · Additional proxy material | Sep 8, 2022 | Meeting notice | SEC |
| 8-K · Current report | Sep 8, 2022 | Material contract | SEC |
| UPLOAD · Letter from the SEC | Aug 29, 2022 | Other filings | SEC |
| 10-K · Annual report | Aug 29, 2022 | Annual report | SEC |
| CORRESP · Letter to the SEC | Aug 18, 2022 | Other filings | SEC |
| PRER14A | Aug 18, 2022 | Other filings | SEC |
| 8-K · Current report | Aug 17, 2022 | Financing | SEC |
| UPLOAD · Letter from the SEC | Aug 8, 2022 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 25, 2022 | Other filings | SEC |
| PRER14A | Jul 25, 2022 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 12, 2022 | Other filings | SEC |
| DEFA14A · Additional proxy material | Jul 7, 2022 | Meeting notice | SEC |
| 8-K · Current report | Jul 7, 2022 | Current report | SEC |
| PREM14A | Jun 15, 2022 | Other filings | SEC |
| 8-K · Current report | Jun 10, 2022 | Material contract | SEC |
| DEFA14A · Additional proxy material | Jun 10, 2022 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jun 1, 2022 | Meeting notice | SEC |
| 8-K · Current report | Jun 1, 2022 | Material contract | SEC |
| 10-Q · Quarterly report | May 25, 2022 | Quarterly report | SEC |
| 425 | Apr 12, 2022 | Other filings | SEC |
| 8-K · Current report | Apr 12, 2022 | Material contract | SEC |
| SC 13G/A · Big-stake notice, amended | Mar 24, 2022 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Mar 7, 2022 | Quarterly report | SEC |
| SC 13G · Big-stake notice | Feb 14, 2022 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Feb 14, 2022 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Feb 14, 2022 | Big-stake notice | SEC |
This page holds 200 of 248 filings. Open Filings
Cap table
Built by 6ix from EUDA Health Holdings Limited’s releases
- Common shares
- 2,994,325
- Fully diluted
- 2,994,325
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 2,994,325 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 2,994,325 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alexander K Arrow Other companies: 8I Enterprises Acquisition Corp (Director · Mar 27, 2019 – Mar 27, 2019 · Past); Protagenic Therapeutics, Inc. (Chief Financial Officer · Oct 16, 2017 – Mar 25, 2024 · Past) | Director · Nov 22, 2021 – Nov 22, 2021 · Past |
| Ajay Raipal Other companies: 8I Enterprises Acquisition Corp (Director · Mar 27, 2019 – Mar 27, 2019 · Past) | Director · Nov 22, 2021 – May 22, 2023 · Past |
| Guan Hong William Yap Other companies: 8I Enterprises Acquisition Corp (Chief Financial Officer, Director · Mar 27, 2019 – Mar 27, 2019 · Past) | Chief Financial Officer, Director · Nov 22, 2021 – Nov 22, 2021 · Past |
| Meng Dong Tan Other companies: 8I Enterprises Acquisition Corp (Director · Mar 27, 2019 – Apr 4, 2019 · Past) | Chief Executive Officer, Director · Nov 22, 2021 – Nov 24, 2021 · Past |
| Alfred Lim | CEO · Since at least Nov 17, 2022 |
| Bo Huang | Director · Since at least Mar 18, 2026 |
| Chern Yong Lew | Director · Since at least Mar 18, 2026 |
| David Francis Capes | Director · Nov 17, 2022 – Nov 17, 2022 · Past |
| Johnson Tang | Managing Director, EUDA Health Malaysia Sdn Bhd · Since at least Nov 5, 2026 |
| Kim Hing Chan | Director · Nov 17, 2022 – Nov 17, 2022 · Past |
All 17 people
| Person | Seat |
|---|---|
| KongYew Wong | Director · May 22, 2023 – May 22, 2023 · Past |
| Kwong Yeow Liew | Director · Since at least Mar 18, 2026 |
| Steven John Sobak | CHIEF FINANCIAL OFFICER · Nov 17, 2022 – Nov 17, 2022 · Past |
| Thien Su Gerald Lim | Director · Nov 17, 2022 – Nov 17, 2022 · Past |
| Vivian Tay | Interim Chief Financial Officer · Since at least Nov 5, 2026 |
| Wei Wen Kelvin Chen | CHIEF EXECUTIVE OFFICER, Director · Nov 17, 2022 – Jun 12, 2023 · Past |
| Whye Shin Tay | Chief Financial Officer · Since at least Mar 18, 2026 |
Log in to ask 6ix AI your own questions about EUDA Health Holdings Limited.